TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Therefore, future research might assess in vitro effects of NTX treatment in the restoration of physiological TRPM3 in NK cells and also the potential pharmacological benefit of LDN in post COVID-19 condition patients, as previously indicated in ME/CFS patients.